Antibiotic-loaded bone cement and periprosthetic joint infection

Journal of Long-Term Effects of Medical Implants

Volumn 24, Issue 2-3, 2014, Pages 89-98

  Chen, Antonia F ^a   Parvizi, Javad ^a  

^a ROTHMAN INSTITUTE   (United States)

Author keywords

Antibiotic cement; Dynamic spacer; Elution; Gentamicin; Periprosthetic joint infection; Static spacer; Tobramycin; Vancomycin

Indexed keywords

ANTIBIOTICS; CEMENTS; MIXING; ORTHOPEDICS;

ELUTION; GENTAMICIN; PERIPROSTHETIC JOINT INFECTION; STATIC SPACER; TOBRAMYCIN; VANCOMYCIN;

ARTHROPLASTY;

AMIKACIN; ANTIBIOTIC BONE CEMENT; CEFAZOLIN; CEFTAZIDIME; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; CREATININE; DAPTOMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN BONE CEMENT; PIPERACILLIN; TEICOPLANIN; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BONE CEMENT; GENTAMICIN;

ACUTE KIDNEY FAILURE; ANTIBIOTIC BONE CEMENT DEVICE; ANTIBIOTIC RESISTANCE; ARTHROPLASTY; ARTICLE; BONE CEMENT DEVICE; CEMENT SPACER; DISLOCATION; DRUG DELIVERY SYSTEM; ELUTION; FRACTURE; HUMAN; INTERSTITIAL NEPHRITIS; INTRAMEDULLARY NAIL; META ANALYSIS (TOPIC); MINIMUM INHIBITORY CONCENTRATION; OSTEOLYSIS; PERIPROSTHETIC JOINT INFECTION; POROSITY; REIMPLANTATION; STAPHYLOCOCCUS AUREUS; TENSILE STRENGTH; VACUUM; CHEMISTRY; DIFFUSION; JOINT PROSTHESIS; MECHANICAL STRESS; PROCEDURES; PROSTHESIS-RELATED INFECTIONS; REPLACEMENT ARTHROPLASTY; SURGICAL WOUND INFECTION;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT; BONE CEMENTS; DIFFUSION; GENTAMICINS; HUMANS; JOINT PROSTHESIS; POROSITY; PROSTHESIS-RELATED INFECTIONS; STRESS, MECHANICAL; SURGICAL WOUND INFECTION; TENSILE STRENGTH; TOBRAMYCIN; VANCOMYCIN;

EID: 84906515470     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.2013010238     Document Type: Article

References (68)

1. Pignatti G, Nitta S, Rani N, Dallari D, Sabbioni G, Stagni C, and Giunti A. Two stage hip revi-sion in periprosthetic infection: results of 41 cases. Open Ortho J. 2010;4:193-200.
2. Kelm J, Bohrer P, Schmitt E, and Anagnostakos K. Treatment of proximal femur infections with antibiotic-loaded cement spacers. Int J Med Sci. 2009;6(5):258-64.
3. Griffin JW, Guillot SJ, Redick JA, and Browne JA. Removed antibiotic-impregnated cement spacers in two-stage revision joint arthroplasty do not show biofilm formation in vivo. J Arthroplasty. 2012;27(10):1796-9.
4. Chiu FY and Lin CF. Antibiotic-impregnated cement in revision total knee arthroplasty. a prospective cohort study of one hundred and eighty-three knees. J Bone Joint Surg Am. 2009;91(3):628-33.
5. Youngman JR, Ridgway GL, and Haddad FS. Antibiotic-loaded cement in revision joint replacement. Hospital Med. 2003;64(10):613-6.
6. Jiranek WA, Hanssen AD, and Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am. 2006;88(11):2487-500.
7. Malchau H, Herberts P, and Ahnfelt L. Prognosis of total hip replacement in Sweden. Follow-up of 92,675 Operations Performed 1978-1990. Acta Ortho Scand. 1993;64(5):497-506.
8. Smabrekke A, Espehaug B, Havelin LI, and Furnes O. Operating time and survival of primary total hip replacements: an analysis of 31,745 primary cemented and uncemented total hip replacements from local hospitals reported to the Norwegian Arthroplasty Register 1987-2001. Acta Ortho Scand. 2004;75(5):524-32.
9. Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003;36(9):1157-61.
10. Jerry GJ, Jr., Rand JA, and Ilstrup D. Old sepsis prior to total knee arthroplasty. Clin Ortho Rel Res. 1988;236:135-40.
11. Lee GC, Pagnano MW, and Hanssen AD. Total knee arthroplasty after prior bone or joint sepsis about the knee. Clin Ortho Rel Res. 2002;404:226-31.
12. Havelin LI, Engesaeter LB, Espehaug B, Furnes O, Lie SA, and Vollset SE. The Norwegian Arth-roplasty Register: 11 years and 73,000 arthroplasties. Acta Ortho Scand. 2000;71(4):337-53.
13. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, and Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian Arthroplasty Register, 1987-1995. J Bone Joint Surg Brit. 1997;79(4):590-5.
14. Bozic KJ and Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87(8):1746-51.
15. Parvizi J, Saleh KJ, Ragland PS, Pour AE, and Mont MA. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Ortho. 2008;79(3): 335-41.
16. Srivastav AK, Nadkarni B, Srivastav S, Mittal V, and Agarwal S. Prophylactic use of antibiotic-loaded bone cement in primary total knee arthroplasty: justified or not? Indian J Ortho. 2009;43(3): 259-63.
17. Randelli P, Evola FR, Cabitza P, Polli L, Denti M, and Vaienti L. Prophylactic use of antibiotic- loaded bone cement in primary total knee replacement. Knee Surg Sports Trauma Arthro. 2010;18(2):181-6.
18. Penner MJ, Masri BA, and Duncan CP. Elution Characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty. 1996;11(8):939-44.
19. Marra F, Robbins GM, Masri BA, Duncan C, Wasan KM, Kwong EH, and Jewesson PJ. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Canadian journal of surgery. J Can Chirurgie. 2001;44(5):383-6.
20. Goss B, Lutton C, Weinrauch P, Jabur M, Gillett G, and Crawford R. Elution and mechanical properties of antifungal bone cement. J Arthroplasty. 2007;22(6):902-8.
21. Azzam K, Parvizi J, Jungkind D, Hanssen A, Fehring T, Springer B, Bozic K, Della Valle C, Pulido L, and Barrack R. Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am. 2009;91(Suppl 6):142-9.
22. Anagnostakos K, Kelm J, Schmitt E, and Jung J. Fungal Periprosthetic hip and knee joint infections clinical experience with a 2-stage treatment protocol. J Arthroplasty. 2012;27(2):293-8.
23. Nelson CL. The current status of material used for depot delivery of drugs. Clin Ortho Rel Res. 2004;427:72-8.
24. Ferraris S, Miola M, Bistolfi A, Fucale G, Crova M, Masse A, and Verne E. In vitro comparison between commercially and manually mixed antibiotic-loaded bone cements. J Applied Biomat Biomech. 2010;8(3):166-74.
25. Hsieh PH, Huang KC, and Tai CL. Liquid gentamicin in bone cement spacers: In vivo antibiotic release and systemic safety in two-stage revision of infected hip arthroplasty. J Trauma. 2009;66(3):804-8.
26. Chang Y, Tai CL, Hsieh PH, and Ueng SW. Gentamicin in bone cement: a potentially more effective prophylactic measure of infectionin joint arthroplasty. Bone Joint Res. 2013;2(10):220-6.
27. Scott CP and Higham PA. Antibiotic bone cement for the treatment of pseudomonas aeruginosa in joint arthroplasty: comparison of tobramycin and gentamicin-loaded cements. J Biomed Mat Res B Appl Biomat. 2003;64(2):94-8.
28. Mclaren RL, Mclaren AC, and Vernon BL. Generic tobramycin elutes from bone cement faster than proprietary tobramycin. Clin Ortho Rel Res. 2008;466(6):1372-6.
29. Streuli JC, Exner GU, Reize CL, Merkofer C, Scott CP, and Zbinden R. In vitro inhibition of coagulase-negative staphylococci by vancomycin/ aminoglycoside-loaded cement spacers. Infection. 2006;34(2):81-6.
30. Brock HS, Moodie PG, Hendricks KJ, and Mciff TE. Compression strength and porosity of single-antibiotic cement vacuum-mixed with vancomycin. J Arthroplasty. 2010;25(6):990-7.
31. Corona PS, Barro V, Mendez M, Caceres E, and Flores X. Industrially prefabricated cement spacers: do vancomycin- and gentamicin-impregnated spacers offer any advantage? Clin Ortho Rel Res. 2013. [Epub ahead of print.]
32. Cerretani D, Giorgi G, Fornara P, Bocchi L, Neri L, Ceffa R, Ghisellini F, and Ritter MA. The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study. J Arthroplasty. 2002;17(5):619-26.
33. Lewis G. Properties of antibiotic-loaded acrylic bone cements for use in cemented arthroplasties: a state-of-the-art review. J Biomed Mat Res B Appl Biomat. 2009;89(2):558-74.
34. Fink B, Vogt S, Reinsch M, and Buchner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Ortho Rel Res. 2011;469(11):3141-7.
35. Klekamp J, Dawson JM, Haas DW, Deboer D, and Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty. 1999;14(3):339-46.
36. Bridgens J, Davies S, Tilley L, Norman P, and Stockley I. Orthopaedic bone cement: do we know what we are using? J Bone Joint Surg Brit. 2008;90(5):643-7.
37. Dicicco M, Duong T, Chu A, and Jansen SA. Tobramycin and gentamycin elution analysis between two in situ polymerizable orthopedic composites. J Biomed Mat Res B Appl Biomat. 2003;65(1): 137-49.
38. Lawson KJ, Marks KE, Brems J, and Rehm S. Vancomycin vs tobramycin elution from polymethylmethacrylate: an in vitro study. Orthopedics. 1990;13(5):521-4.
39. Simpson PM, Dall GF, Breusch SJ, and Heisel C. [In vitro elution and mechanical properties of antibiotic-loaded smartset HV and palacos R acrylic bone cements]. Der Orthopade, 2005;34(12):1255-62.
40. Bertazzoni Minelli E, Caveiari C, and Benini A. Release of antibiotics from polymethylmethacrylate cement. J Chemother. 2002;14(5):492-500.
41. Neut D, De Groot EP, Kowalski RS, Van Horn JR, Van Der Mei HC, and Busscher HJ. gentamicin-loaded bone cement with clindamycin or fusidic acid added: biofilm formation and antibiotic release. J Biomed Mat Res A. 2005;73(2):165-70.
42. Postak PD and Greenwald AS. Assuring cement fixation: all mixing systems are not the same. Proc Am Acad Orthop Surg. 2003;4:656.
43. Meyer J, Piller G, Spiegel CA, Hetzel S, and Squire M. Vacuum-mixing significantly changes antibiotic elution characteristics of commercially available antibiotic-impregnated bone cements. J Bone Joint Surg Am. 2011;93(22):2049-56.
44. Postak PD and Greenwald AS. The influence of antibiotics on the fatigue life of acrylic bone cement. J Bone Joint Surg Am. 2006;88 Suppl 4:148-55.
45. Amin TJ, Lamping JW, Hendricks KJ, and Mciff TE. Increasing the elution of vancomycin from high-dose antibiotic-loaded bone cement: a novel preparation technique. J Bone Joint Surg Am. 2012;94(21):1946-51.
46. Silvestre A, Almeida F, Renovell P, Morante E, and Lopez R. Revision of infected total knee arthroplasty: two-stage reimplantation using an antibiotic-impregnated static spacer. Clin Ortho Surg. 2013;5(3):180-7.
47. Fleck EE, Spangehl MJ, Rapuri VR, and Beauchamp CP. An articulating antibiotic spacer controls infection and improves pain and function in a degenerative septic hip. Clin Ortho Rel Res. 2011;469(11):3055-64.
48. Van Thiel GS, Berend KR, Klein GR, Gordon AC, Lombardi AV, and Della Valle CJ. intraoperative molds to create an articulating spacer for the infected knee arthroplasty. Clin Ortho Rel Res. 2011;469(4):994-1001.
49. Hsieh PH, Shih CH, Chang YH, Lee MS, Shih HN, and Yang WE. Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am. 2004;86-A(9):1989-97.
50. Antoci V, Phillips MJ, Antoci V, Jr., and Krackow KA. Using an antibiotic-impregnated cement rod-spacer in the treatment of infected total knee arthroplasty. Am J Ortho. 2009;38(1):31-3.
51. Antoci V, Phillips MJ, Antoci V, Jr., and Krackow KA. The treatment of recurrent chronic infected knee arthroplasty with a 2-stage procedure. J Arthroplasty. 2009;24(1):159 e13-7.
52. Macmull S, Bartlett W, Miles J, Blunn GW, Pollock RC, Carrington RW, Skinner JA, Cannon SR, and Briggs TW. Custom-made hinged spacers in revision knee surgery for patients with infection, bone loss and instability. Knee. 2010;17(6):403-6.
53. Sherman SL, Cunneen KP, Walcott-Sapp S, Brause B, and Westrich GH. Custom total femur spacer and second-stage total femur arthroplasty as a novel approach to infection and periprosthetic fracture. J Arthroplasty. 2008;23(5):781-6.
54. Ben-Lulu O, Farno A, Gross AE, Backstein DJ, Kosashvili Y, and Safir OA. A modified cement spacer technique for infected total hip arthroplasties with significant bone loss. J Arthroplasty. 2012;27(4):613-9.
55. Luu A, Syed F, Raman G, Bhalla A, Muldoon E, Hadley S, Smith E, and Rao M. Two-stage arthroplasty for prosthetic joint infection: a systematic review of acute kidney injury, systemic toxicity and infection control. J Arthroplasty. 2013;28(9):1490-8 e1.
56. Kalil GZ, Ernst EJ, Johnson SJ, Johannsson B, Polgreen PM, Bertolatus JA, and Clark CR. Systemic exposure to aminoglycosides following knee and hip arthroplasty with aminoglycoside-loaded bone cement implants. Ann Pharmacother. 2012;46(7-8):929-34.
57. Van Raaij TM, Visser LE, Vulto AG, and Verhaar JA. Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty. J Arthroplasty. 2002;17(7):948-50.
58. Menge TJ, Koethe JR, Jenkins CA, Wright PW, Shinar AA, Miller GG, and Holt GE. Acute kidney injury after placement of an antibiotic-impregnated cement spacer during revision total knee arthroplasty. J Arthroplasty. 2012;27(6):1221-7 e1-2.
59. Mcglothan KR and Gosmanova EO. A case report of acute interstitial nephritis associated with antibiotic-impregnated orthopedic bone-cement spacer. Tennessee Med. 2012;105(9):37-40, 42.
60. Patrick BN, Rivey MP, and Allington DR. Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother. 2006;40(11):2037-42.
61. Haydon RC, Blaha JD, Mancinelli C, and Koike K. Audiometric thresholds in osteomyelitis patients treated with gentamicin-impregnated methylmethacrylate beads (Septopal). Clin Ortho Rel Res;1993(295):43-6.
62. Springer BD, Lee GC, Osmon D, Haidukewych GJ, Hanssen AD, and Jacofsky DJ. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Ortho Rel Res. 2004;(427):47-51.
63. Dairaku K, Takagi M, Kawaji H, Sasaki K, Ishii M, and Ogino T. Antibiotics-impregnated cement spacers in the first step of two-stage revision for infected totally replaced hip joints: report of ten trial cases. J Ortho Sci Japan. 2009;14(6):704-10.
64. Anagnostakos K, Jung J, Schmid NV, Schmitt E, and Kelm J. Mechanical complications and reconstruction strategies at the site of hip spacer implantation. Int J Med Sci. 2009;6(5):274-9.
65. Costanzo JA, Tokarski A, Uhr A, Patel R, Chen AF, Deirmengian CA, and Deirmengian GK. Mechanical complications of hip and knee spacers are common. Eur Bone Joint Infect Soc. 2013. Prague, Czech Republic.
66. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, Hanna D, and Ramage G. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Brit. 1998;80(4):568-72.
67. Hope PG, Kristinsson KG, Norman P, and Elson RA. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Brit. 1989;71(5):851-5.
68. Fletcher MD, Spencer RF, Langkamer VG, and Lovering AM. Gentamicin concentrations in diagnostic aspirates from 25 patients with hip and knee arthroplasties. Acta Ortho Scand. 2004;75(2):173-6.